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ABSTRACT 
 
Breast cancer is the most prevalent malignancy among women in developed 
countries, including Portugal, showing the highest incidence and mortality rates. Efforts 
have been made to find new strategies to improve the therapeutic approaches in breast 
cancer. Targeted molecular therapies might be part of the solution, mainly if these are 
able to inhibit key proteins that promote resistance to conventional therapeutic strategies 
(chemo and radiotherapy).  
 P-cadherin is a calcium-dependent glycoprotein responsible for cell-cell adhesion, 
and promotes migration and invasion of breast cancer cells. Its overexpression occurs in 
high-grade invasive breast carcinomas and was correlated with tumour aggressiveness 
and poor patient prognosis, since P-cadherin-positive carcinomas were significantly 
associated with short-term overall and disease-free survival, as well as with distant and 
loco-regional relapse-free interval. Furthermore, P-cadherin expression has also been 
positively associated with well-established markers of poor prognosis.  
Our group has showed that P-cadherin is a cancer stem cell biomarker with direct 
relevance in the stem cell activity of basal-like breast cancer cells. Importantly, we found 
that P-cadherin expression confers cancer cell resistance to X-ray-induced cell death; 
however, the molecular mechanism involved in this resistance is not yet clarified.  
  We have designed the present study to test whether the DDR/R pathway could be 
responsible by the resistance to death by cells with high levels of P-cadherin, since this 
signalling pathway is usually connected to cancer cell resistance to DNA insults provoked 
by standard cancer therapies. For this purpose, we used MCF10A, a normal-like cell line, 
and BT-20, a malignant basal-like breast cancer cell line, being both positive for P-
cadherin expression, and investigated the cellular response to different types of DNA 
stress-inducing stimuli before and after P-cadherin silencing. The treatments were 
performed with three different cell-death inducing agents, hydrogen peroxide (H2O2), UV 
light (UV) and Taxol. Then, cell cycle profile was evaluate by FACS, cell death/apoptosis 
by PI/Annexin V assay, stem cell activity by mammosphere assay, DNA damage by comet 
assay and уH2AX foci, and expression of DDR/R proteins by western blot. 
Both cell lines were very sensitive to UV irradiation exhibiting elevated cell death. 
The treatments with H2O2 and Taxol showed a significant reduction in the stem cell 
population which, after P-cadherin knock-down, showed a tendency to decrease further in 
both cell lines. The three DNA stress-inducing agents increased DNA damage, which was 
further increased by P-cadherin silencing in both cell lines, MCF10A and BT-20. A 
possible crosstalk between DDR/R pathway and P-cadherin may exist in order to promote 
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this DNA damage resistance. Cell death was increased by P-cadherin silencing in the 
presence of H2O2 and Taxol in both cell lines MCF10A and BT-20 and in the absence of 
any stimuli in the normal-like cell line. As expected, we found that H2O2, UV light and 
Taxol (in a lower extent) were able to induce several players of the DDR/R pathway. 
Interestingly, P-cadherin inhibition had also an impact in the expression of these 
molecules. 
Although further experiments still need to be performed, our work points to the 
idea that P-cadherin silencing could increase the sensitization of these cells to DNA 
damaging agents, becoming a potential therapeutic approach in concomitant 
administration with conventional treatments, as chemo- or radiation therapy.  
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RESUMO 
 
O carcinoma da mama é a neoplasia que apresenta as taxas mais elevadas de 
prevalência nas mulheres, assim como elevadas taxas de incidência e mortalidade nos 
países desenvolvidos, incluindo Portugal. Vários esforços têm sido realizados no sentido 
de encontrar novas estratégias para melhorar as abordagens terapêuticas no âmbito 
desta neoplasia. As terapias alvo podem ser parte da solução, principalmente se inibirem 
proteínas chave que promovam a resistência às terapias convencionais (quimio e 
radioterapia). 
 A P-caderina é uma glicoproteína dependente do cálcio, responsável pela adesão 
célula–célula, promovendo a migração e capacidade invasiva de células de cancro da 
mama. A sua sobre-expressão ocorre em carcinomas da mama invasivos de alto grau e 
está correlacionada com agressividade tumoral e mau prognóstico dos pacientes, visto 
que carcinomas P-caderina positivos estão significativamente associados com uma curta 
sobrevida total e tempo livre de doença, como a um intervalo livre de recorrência distante 
e/ou locoregional. Mais ainda, a expressão da P-caderina tem sido positivamente 
associada com marcadores de mau prognóstico.  
 O nosso grupo mostrou que a P-caderina é um biomarcador de células estaminais 
com relevância direta na atividade estaminal de células de carcinoma da mama do tipo 
basal. De facto, foi mostrado que a expressão da P-caderina confere resistência à morte 
de células tumorais expostas a raios-X; no entanto, os mecanismos envolvidos nesta 
resistência ainda não foram clarificados. 
Realizamos o presente estudo no sentido de testar se via DNA damage 
response/repair (DDR/R) é responsável por mediar a resistência à morte em células que 
apresentem altos níveis de expressão da P-caderina, visto que esta via está usualmente 
ligada à resistência a danos no DNA induzidos pelas terapias standard. Para alcançar 
este objetivo, usamos a linha celular normal MCF10A e a linha maligna basal, BT-20, 
sendo as duas positivas para a expressão da P-caderina, e investigamos a resposta 
celular a diferentes estímulos indutores de stress no DNA antes e depois do 
silenciamento da P-caderina. Estes tratamentos foram realizados utilizando três agentes 
indutores de morte celular, nomeadamente, peróxido de hidrogénio (H2O2), luz UV e 
Taxol. Depois, avaliamos o perfil do ciclo celular por FACS, apoptose/morte celular pelo 
ensaio PI/Annexin V, a atividade estaminal pelo ensaio de mamosferas, os danos no DNA 
pelo ensaio do cometa e pela avaliação de уH2AX foci e expressão de proteínas 
envolvidas da via DDR/R por western blot.  
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 Ambas as linhas celulares foram bastante sensíveis à radiação UV, apresentando 
uma elevada morte celular. Os tratamentos com H2O2 e Taxol mostraram uma 
significativa redução da população celular estaminal que, após o silenciamento da P-
caderina, mostrou uma tendência para diminuir, ainda mais, nas duas linhas celulares. Os 
três estímulos usados no nosso trabalho aumentaram os danos no DNA, sendo 
incrementados pelo silenciamento da P-caderina nas duas linhas celulares, MCF10A e 
BT-20. Um possível correlação entre a P-caderina e a via DDR/R poderá existir no 
sentido de promover resistência a danos no DNA. A morte celular aumentou nas duas 
linhas, MCF10A e BT-20, após silenciamento da P-caderina na presença de H2O2 e Taxol 
e sem nenhum estímulo na linha normal – MCF10A. Como esperado, verificamos que o 
H2O2, luz UV e, em menor extensão, o Taxol foram capazes de induzir vários elementos 
da via DDR/R. De salientar, que a inibição da expressão da P-caderina também teve um 
impacto na expressão destas moléculas. 
 Embora seja necessário realizar mais estudos, o nosso trabalho indica que o 
silenciamento da P-caderina pode aumentar a sensibilidade destas células para os 
agentes indutores de danos no DNA, tornando-se num potencial alvo-terapêutico com a 
concomitante administração dos tratamentos convencionais, tais como a quimo e 
radioterapia 
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1. Breast  
 
1.1 Morphology 
 
The human breast is a bilateral organ that undergoes a series of changes from 
intrauterine life to senescence (Russo and Russo, 2004; Howard and Veltmaat, 2013). 
The mammary gland morphogenesis encompasses a sequential of developmental stages 
that begins during embryonic development and proceeds postnatally through puberty, 
pregnancy, lactation, and involution, which correspond to a period of cell proliferation, 
apoptosis, and differentiation, in conjunction with changes in gene expression patterns 
and regarded as a succession of cell fate determinations (Russo and Russo, 2004; 
Topper and Freeman, 1980).  
The mammary gland is composed of epithelial and stromal tissues. The first is 
characterized by a branching network of ducts and alveoli that end in clusters of small 
ductules that constitute the terminal ductal lobular units (TDLUs) with a central lumen that 
opens to the surface body through the nipple. The epithelium of the mammary gland is 
composed of two main cellular lineages: luminal cells that surround a central lumen and 
undergo functional differentiation in pregnancy to produce milk; and highly elongated 
myoepithelial cells, located in a basal position adjacent to the basement membrane, which 
are contractile and participate in the milk delivery. The second is constituted by stromal 
elements that comprehend fibroblasts, endothelial cells, macrophages, adipocytes and 
neurons, collectively referred to as the mammary fat pad that embeds the epithelial 
elements (Figure 1A) (Visvader, 2009; Neville et al., 1998; Hennighausen and Robinson, 
2005; Visvader and Stingl, 2014). 
 The mammary gland arises from embryonic ectoderm as the result of reciprocal 
epithelial and mesenchymal interactions; cell growth, morphogenesis, and 
cytodifferentiation occur, so eventually a rudimentary system of ducts is formed by the 
time of birth, remaining quiescent until puberty (Topper and Freeman, 1980; Howard and 
Veltmaat, 2013; Russo and Russo, 2004; Robinson et al., 1999). At this stage, most 
epithelial cells express receptors for oestrogen and progesterone to enable these 
hormones to stimulate ductal outgrowth and branching, as well as alveolar expansion, 
namely by regulating cell proliferation and cellular turnover in the oestrous cycle. This 
ductal growth has conspicuous, club-shaped structures at the tips, which are known as 
terminal end buds (TEB). These are composed by an outer layer of cap cells, which are 
I.INTRODUCTION 
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stem cells that will originate the basal cells, and the more centrally located body cells, 
which are stem cells that will originate the luminal cells. Once the entire fat pad has been 
filled with ducts, TEB disappear (Hennighausen and Robinson, 2005). 
During pregnancy, additionally to progesterone, prolactin and oxytocin lead to 
structural alterations in the mammary gland, occurring the alveologenesis. This process 
consists in alveoli formation from the proliferation and maturation of side branches that 
contain TDLUs, responsible for milk production. So, during lactation, alveoli are fully 
matured and the luminal cells synthesize and secrete milk components into the lumen 
(Visvader and Stingl, 2014; Hennighausen and Robinson, 2005; Tiede and Kang, 2011). 
After lactation, the alveolar cells are subject to programmed cell death during the process 
of involution. During successive rounds of pregnancy and involution, the TDLUs expand 
and decrease in size, with an increase and subsequent decrease in the number of acini 
(Hennighausen and Robinson, 2005; Howard and Gusterson, 2000). In contrast, during 
postmenopausal involution, both lobules and ducts are reduced in number and the 
intralobular stroma is replaced by collagen, whereas the glandular epithelium and the 
interlobular tissue regress and are replaced by fat (Howard and Gusterson, 2000).  
The mammary epithelium expansion during puberty and pregnancy, together with 
apparent remarkable regenerative capacity occurring during successive reproductive 
cycles, suggests the existence of mammary stem cells (Kordon and Smith, 1998; Visvader 
and Stingl, 2014). This implicates a cellular hierarchical differentiation, where a stem cell 
is localized at the apex and has extraordinary capacity to self-renew, proliferate and 
differentiate into multiples lineages (Figure 1B). It is thought that mammary stem cells 
reside in a basal position and give rise to both lineages of progenitor cells and of fully 
differentiated cells (Visvader, 2009).  
Several in vitro and in vivo studies have been performed in order to find markers 
that would characterize mammary stem cells (Kordon and Smith, 1998; Tiede and Kang, 
2011).  One of the most interesting studies performed demonstrates the generation of a 
functional mammary gland from a single stem cell and suggests that distinct cellular 
progenitors for ductal and lobular structures exist in the mammary gland. Some adhesion 
proteins, like β1-integrin and α6-integrin, might have an active role in mediating these 
interactions (Shackleton et al., 2006; Stingl et al., 2006). 
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Figure 1 – (A) Schematic representation of the different tissues composing the human adult 
mammary gland; (B) Representation of the model of differentiation hierarchy within human 
mammary epithelium. Adapted from Visvader et al. (2009)   
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2. Breast cancer 
 
 2.1 Epidemiology  
                     
According to data provided by Globocan, breast cancer is the most incident and 
prevalent malignancy with high mortality rates among women. Incidence rates are high in 
developed countries, whereas rates in less developed countries are low but increasing 
(Figure 2A) (Ferlay J et al., 2013; Key et al., 2001). 
In Portugal, this is not an exception, being diagnosed 6088 new cases per year, 
which corresponds to 29.4% of the total malignancies in women. In terms of mortality and 
prevalence (in 5 years), the numbers are 1570 (16.0%) and 24284 (40.1%), respectively 
(Figure 2B) (Ferlay J et al., 2013). 
 
 
 
 
 
  
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
Figure 2 - The total annual numbers for the incidence and mortality rates of the most common types 
of cancer for both sexes in World (A) and in Portugal (B) – estimates presented for the year 2012 by 
GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 
(Ferlay et al., 2013). 
A B 
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2.2 Risk Factors  
 
The age is the main risk factor indicated for the development of this neoplasia 
(Forbes, 1997). Additionally, association of some genetic, biological, and environmental 
factors also increases the risk for the development of breast cancer, namely early 
menarche, late menopause, and obesity in postmenopausal women, which permits a long 
breast exposure to elevated levels of oestrogens. The breast cancer family history, 
associated with mutations for BRCA1/2 genes, also contributes for an increased risk of 
about 80% to the development of this neoplasia. Furthermore, alcohol consumption, 
smoke, late pregnancy, oral contraceptives, hormonal therapy for menopause and ionising 
radiation exposure are described as risk factors for breast cancer development. On the 
other hand, childbearing reduces the risk, with greater protection for early first birth and a 
larger number of births. Breastfeeding has also a protective effect, as well as physical 
activity (Key et al., 2001). 
 
 
2.3 Molecular subtypes  
 
Breast carcinomas represent a heterogeneous group of tumours, that diverse in 
behaviour, outcome and response to therapy (Sorlie et al., 2001; Sorlie et al., 2003). For 
many decades, invasive breast carcinomas were only classified according to the 
histological type, grade, and hormone receptors expression (Lacroix et al., 2004). 
However, development of microarrays throughput technologies created a molecular 
system classification, which allowed to correlate these malignancies at the molecular level 
with above indicated clinical parameters, as well as to predict the outcome and improve 
the therapy selection. Thus, it was proposed the following molecular subtypes for breast 
carcinomas: Luminal, HER2 OE and triple negative carcinomas (Sorlie et al., 2001; Sorlie 
et al., 2003; Sotiriou et al., 2003; Perou et al., 2000). 
Luminal breast carcinomas account for 60% to 75% of breast carcinomas. Within 
this group, it is defined luminal A and B. Luminal A express ER and PgR being therapeutic 
targets for antagonists of ER, such as tamoxifen or fulvestrant, or for aromatase inhibitors, 
namely anastrozole or letrozole. Concerning luminal B subtype, besides the hormonal 
receptors expression, these also have HER2-OE and high rates of cell proliferation (Sorlie 
et al., 2001).   
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HER2-OE tumours lack hormonal receptors expression, but overexpress HER2 
protein, which is highly associated with gene amplification. In this type of tumours, 
trastuzumab or lapatinib are used as therapy (Perou et al., 2000). 
Triple-negative carcinomas are a heterogeneous group of tumours and represent 
10% to 17% of all breast carcinomas. These usually show poor prognosis, once they lack 
ER, PgR and HER2 expression and are associated with aggressive histological features 
and poor patient survival (Sotiriou et al., 2003; Sorlie et al., 2003; van 't Veer et al., 2002). 
These tumours are characterized to express basal markers, as CK5, CK14, EGFR, P-
cadherin and Vimentin (Sousa et al., 2010; Yehiely et al., 2006) .  
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3. P-cadherin 
 
3.1 Localization, tissue distribution and function in normal tissues 
 
P-cadherin (placental) is a calcium-dependent cell-cell adhesion protein encoded 
by the CDH3 gene (chromosome 16q22.1) belonging to the classical family of adherens-
type junctions, that comprises other cadherin family members, namely, CDH1/E-cadherin 
(epithelial), CDH2/N-cadherin (neuronal) and CDH4/R-cadherin (retinal) (Yilmaz and 
Christofori, 2010). P-cadherin was the third classical cadherin to be identified and 
characterized in the mouse visceral endoderm cell line PSA5-E (Nose and Takeichi, 
1986).  Structurally, P-cadherin is constituted by three distinct domains, namely, the 
extracellular, that mediates homotypic  stable cell to cell interactions, the transmembrane 
and the intracellular, that binds to the actin cytoskeleton through a catenin complex (α, β 
and p-120 catenins) (Green et al., 2010; Paredes et al., 2007).  The mature P-cadherin 
has a molecular weight of 118 kDa and its structure is similar to that of classical cadherins 
but different from those of E-cadherin and N-cadherin in terms of immunological specificity 
and molecular mass (Nose and Takeichi, 1986). 
Similarly to other family cadherin members, P-cadherin has a role in maintaining 
the structural integrity of epithelial tissues, modulating the cell shape, polarity, cell motility 
and participates in differentiation during embryogenesis (Raymond et al., 2009; Cavallaro 
and Dejana, 2011). Additionally, it has been reported as a stem cell marker, not only for 
stem cells identification and characterization, but also as a mediator/modulator of stem 
cell signalling pathways. Some examples are studies performed by Kendrick and 
collaborators   and Raymond and colleagues, which reported P-cadherin as a marker of 
undifferentiated stem or progenitor cells. Kolle et al. also showed that CDH3 is one of the 
genes that encode a surface protein that identify the pluripotent population of human 
embryonic stem cells (Raymond et al., 2009; Kendrick et al., 2008; Kolle et al., 2009).  
P-cadherin name results from the fact that this molecule was originally observed to 
be highly expressed in mouse placenta throughout pregnancy, both in the embryonic and 
maternal regions. The expression of P-cadherin in the uterus begin with its appearance in 
the decidua, into which the extraembryonic cells expressing P-cadherin of implanted 
embryos invade to establish the embryo-maternal connection (Aplin et al., 2009). Although 
P-cadherin expression is high in mouse placenta, it is weakly detectable in human 
placenta and its expression is restricted to trophoblasts adjoin (cytotrophoblast-
cytotrophoblast and cytotrophoblast–syncytiotrophoblast) in the first trimester villus, being 
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determinant for the association between embryonic and maternal tissues (Aplin et al., 
2009). 
In human breast, P-cadherin expression is confined to the basal myoepithelial 
layer of the mammary gland and its expression is maintained along the all gland 
development,  being determinant for normal organization of the tissue (Daniel et al., 
1995). Additionally, a soluble form of P-cadherin in body fluids and milk has been 
described, which molecular weight match with its extracellular domain (80 KDa), although 
its biological role remains unknown (Soler et al., 2002; Mannello et al., 2008). 
Studies performed by Radice et al. further demonstrated the importance of P- 
cadherin expression in modulating the development of the mammary gland since the 
deletion of P-cadherin affects normal mammopoiesis. It has been shown that CDH3-null 
female mice exhibit precocious mammary gland differentiation in the virgin state, as well 
as breast hyperplasia and dysplasia with age. These observations in knockout animals 
indicate P-cadherin cell-cell interactions and signalling as regulatory determinants of the 
negative growth of the luminal epithelium, being important for the maintenance of an 
undifferentiated state of the normal mammary gland, which makes clear the role attributed 
to P-cadherin as a stem cell marker and active in modulating stem signalling pathways 
(Kendrick et al., 2008; Radice et al., 1997).  
Besides breast tissue, P-cadherin expression is described in later development of 
the growing hair follicle, in the early progenitor cells from hair germs and small hair 
placodes, and in the basal layer of adult epithelial tissues such as skin, cervix and lung 
contributing to the maintenance of the epithelial phenotype (Pizarro et al., 1995; Fujita et 
al., 1992).   
Studies performed to uncover the role of P-cadherin in the development and 
architecture of epithelial tissues has demonstrated that P-cadherin loss causes defective 
human syndromes. Furthermore, CDH3 mutations have been shown to cause P-cadherin 
functional inactivation, leading to developmental defects associated with two inherited 
diseases in humans, namely, hypotrichosis with juvenile macular dystrophy (HJMD) and 
ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEM syndrome). The 
common features of both diseases are sparse hair and macular dystrophy of the retina, 
while only EEM syndrome shows the additional finding of split hand/foot malformation 
(SHFM) (Kjaer et al., 2005; Shimomura et al., 2008; Sprecher et al., 2001; Indelman et al., 
2007). 
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3.2 Relevance in breast cancer   
 
Besides P-cadherin function in normal human mammary gland development, it is 
known that it is overexpressed in 20% to 40% of invasive breast carcinomas and in 25% 
of ductal carcinomas in situ (DCIS). In opposite of what has been reported for melanoma, 
where P-cadherin behaves like a tumour suppressor gene and functions as a pro-
adhesive and anti-invasive molecule (Paredes et al., 2007; Paredes et al., 2005; Paredes 
et al., 2002), it was reported that P-cadherin overexpression occurs in high-grade invasive 
breast carcinomas and promotes migration and invasion of breast cancer cells. In fact, its 
expression was correlated with tumour aggressiveness and poor patient prognosis, since 
P-cadherin-positive carcinomas were significantly associated with short-term overall and 
disease-free survival, as well as with distant and loco-regional relapse-free interval. 
Furthermore, P-cadherin expression has also been positively associated with well-
established markers of poor prognosis, like Ki-67, epidermal growth factor receptor 
(EGFR), cytokeratin 5 (CK5), vimentin, p53, and HER2 expression, high mitotic index and 
Figure 3- Schematic representation of the structural components of the P-cadherin adhesive 
junction. P-cadherin extracellular domain interacts with the extracellular domain of an adjacent cell. 
Intracellular catenins bind to the cytoplasmic tail of P-cadherin: p120-catenin binds at the 
juxtamembrane domain (JMD), whereas β-catenin to the distal catenin binding domain (CBD). α-
catenin associates with β-catenin and is directly linked to the actin cytoskeleton. The lower panel 
shows the genomic structure of the CDH3/P-cadherin gene, which is constituted by 16 exons: the 
extracellular part of P-cadherin s encoded by 10 exons (exons 4-13), whereas the transmembrane 
and the intracellular domains are determined by the information coded by the last 3 exons (exons 
14-16). Adapted from Albergaria et al. (2011) 
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decreased cell differentiation. On the other hand, it is negatively associated with age at 
diagnosis, hormonal receptors (ER and PgR), and Bcl-2 expression. Interestingly, none of 
these reports showed a significant association with tumour size, lymph node metastasis 
and angiogenesis (Paredes et al., 2007; Paredes et al., 2002).  
Based on microarray technology, which allowed the linkage between different 
expression profiles and clinical outcomes, it was reported that aberrantly P-cadherin 
expression occurs in basal-like breast carcinomas, which are characterized by lack of 
oestrogen receptor (ER), progesterone receptor (PgR) and HER2, with expression of p63 
and cytokeratin CK5. Actually P-cadherin can identify invasive basal-like carcinomas by 
immunohistochemistry, as well as tumours that usually harbour BRCA1 germline 
mutations, being one of the most useful adjunctive markers for distinguishing the 
precursor DCIS basal-like lesions (Sousa et al., 2010; Paredes et al., 2002). 
The mechanisms how aberrantly P-cadherin expression occurs are still in debate; 
however, some CDH3 repressors and activators have been already identified. BRCA1/c-
myc/sp1 complex and ER are described as repressors, acting directly as transcriptional 
repressor of the CDH3 gene or indirectly through epigenetic alterations in CDH3 gene 
promoter (Gorski et al., 2010; Albergaria et al., 2010). On the other hand, β-catenin, p63 
and C/EBPβ are transcriptional activators of the CDH3 gene (Faraldo et al., 2007; 
Shimomura et al., 2008; Albergaria et al., 2010). 
Additionally, studies have been performed to uncover the mechanisms by which P-
cadherin mediates this aggressive behaviour. It was shown that P-cadherin 
overexpression, in breast cancer cells with wild-type E-cadherin, promotes cell invasion, 
motility and migration. Interestingly, it was also reported that the overexpression of P-
cadherin induces the secretion of matrix metalloproteases, specifically MMP-1 and MMP-
2, which then lead to P-cadherin ectodomain cleavage, being this domain able to induce 
in vitro invasion of breast cancer cells (Ribeiro et al., 2009). Moreover, it was found that P-
cadherin co-localizes with E-cadherin, promoting cell invasion due to the disruption 
caused in the interaction between E-cadherin and cytoplasmic catenins. Additionally, E- 
and P-cadherin co-expressing cells significantly enhanced in vivo tumour growth, 
compared with cells expressing only E- or only P-cadherin. Finally, it was demonstrated 
that co-expression of both molecules was significantly correlated with high-grade breast 
carcinomas, biologically aggressive, and with poor patient survival, being a strong 
prognostic factor in this disease (Ribeiro et al., 2013).  
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3.3 As a cancer stem cell marker  
 
It has been reported that the majority of tissues comprises a population of adult 
stem cells with a role in tissue regeneration after physiologic injury or cell death. To 
accomplish this, these cells harbour particular features, namely self-renewal ability and 
potential to differentiate into a wide range of these lineage committed cells. Thus, it is 
believed that exist a hierarchical organization within adult tissues.    
Similarly to what has been described for normal tissues concerning their 
hierarchical organization, it has been also suggested that neoplasias, including solid 
tumours, can show this same type of organization, with a cancer stem cell at the apex of 
the hierarchy and genetic programmes and biological behaviour similar to those observed 
in normal stem cells in association with properties of malignancy (Jordan et al., 2006; 
Reya et al., 2001; Pardal et al., 2003). In this way, these cancer stem cells (CSCs) share 
with stem cells an unlimited self-renewal capacity through asymmetric cell divisions, 
producing one tumorigenic CSC and one non-tumorigenic cancer cell, resulting in a 
population of phenotypically diverse non-tumorigenic cancer cells that compose the 
tumour bulk.  
Part of this initial supposition was based on the identification and characterization 
of leukemic hematopoietic stem cells, which is the best-known model on this subject. 
Using fluorescence-activated cell sorting (FACS) to isolate cells based on the expression 
of some surface proteins and the dilution transplant assay in nonobese diabetic/severe 
combined immunodeficiency (NOD/SCID) mice, Lapidot et al. and Bonnet and Dick found 
that a small population of cells, with the phenotype CD34+/CD38-,  isolated from the bulk 
tumour population, were the only  with the capacity to initiate tumours and give rise to the 
heterogeneity seen within this type of neoplasia, even if low numbers of this cell 
population was engrafted into the mice (Lapidot et al., 1994; Bonnet and Dick, 1997). 
Based on these results, it was questioned if the same could occur in solid tumours. 
Curiously, breast cancer was the first solid tumour model described as owing a small 
population of cells characterized by CD44+CD24−/low Lineage – phenotype with tumorigenic 
capacity to form tumours in mice even after several dilution passages (Al-Hajj et al., 
2003). Posteriorly, these findings were mentioned in other solid tumours, namely brain 
(Singh et al., 2004),  prostate (Xin et al., 2005) and lung cancers (Kim et al., 2005), among 
others. Additionally, besides the cell surface markers used to isolate this stem cell 
population, other methods were developed, namely sphere-forming assay, based on 
capacity of the CSCs to grown in anoiks conditions and  form spheres, in particular, 
mammospheres (Dontu et al., 2003; Shaw et al., 2012).  
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Based on these studies, it was proposed a cancer stem cell model. According to 
this model, only a subpopulation of cells within the neoplasia is tumorigenic and harbours 
the potential to differentiate into several cancer cell types, which is reflected in tumour 
heterogeneity (Clarke et al., 2006).  In contrast, the previous clonal model states that any 
cell can receive an oncogenic hit, originating mutant tumour cells with growth advantage 
that are selected and expanded through additional mutations, epigenetic events and 
microenvironment modulation. Thus, according to this model the majority of cells within a 
tumour are tumorigenic and contributes equally to heterogeneity (Clarke et al., 2006; 
Visvader and Lindeman, 2012). 
However, the cancer stem cell model remains a topic of discussion. The majority 
of the markers used to identify these cell populations are the ones expressed in normal 
tissues, turning a hard task to differentiate normal from malignant cells. Additionally, it 
remains in discussion which cell gives rise to a cancer stem cell. It is suggested that the 
CSC can derivate from a normal stem cell, progenitor or even from a more differentiated 
cell. This unsolved question highly reflects the misunderstanding seen among several 
authors, concerning the designation attributed to these cells: those that use the term 
cancer stem cell (CSC) and others that prefer tumour initiating cell (TIC).  
Until now, besides CD44, other makers are pointed to better define breast cancer 
stem cells (BCSC) phenotype, such as CD133, ALDH-1, CD49f, Epcam, ESA and more 
recently P-cadherin. However, one of the biggest challenges is to associate these markers 
with a specific molecular subtype of breast carcinomas. Studies from our group used 
basal-like breast cancer cell lines and a serie of invasive breast tumours, which allowed to 
characterize a subpopulation of cells with stem cell behaviour and enriched for P-cadherin 
expression. It was shown not only its utility as a BCSC marker, but also an important role 
in modulating the biologic properties of this cell population. One example was given by the 
studies performed using siRNA and separation in P-cadhigh/P-cadlow cell populations: there 
are significant differences in mammosphere forming efficiency (which measures self-
renew capacity, as well clonogenic capacity of cells). Additionally, it was evaluated the 
tumorigenic capacity of P-cadherin-expressing cells and it was shown that P-cadhigh 
population show a higher capacity to form tumours compared with the P- cadlow 
population, which corroborate the role of P-cadherin in maintaining stem cell properties. 
Moreover, it was demonstrated an association between P-cadherinhigh cell population and 
CD49f, CD44 and ALDH in basal-like breast carcinomas (Vieira et al., 2012). Interestingly, 
we still showed that activation of P-cadherin and α6β4 integrin involves the activation of 
focal adhesion (FAK), Src and AKT kinases, which have repercussions in the stem cell 
and invasive properties induced by P-cadherin to breast cancer cells (Vieira et al., 2014). 
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According to the cancer stem cell model, it is also believed that the small 
population of CSCs is responsible for disease recurrence and therapy resistance. In fact, 
this cell population has particular properties that confer intrinsically resistance to current 
therapies, such as expression of ABC transporters responsible for drugs efflux, staying 
during long periods in state of quiescence, or at least are slow-cycling, which confers 
escape for the majority of chemotherapeutic drugs since they are cell cycle-dependent. 
Additionally, it was reported an enhanced capacity of these cells to survive in conditions of 
hypoxia and resistance to certain forms of apoptotic-related cell death (Krishnamurthy et 
al., 2004; Johnstone et al., 1999). Moreover, this cell population has an enhanced 
capacity to repair DNA damage (Clarke et al., 2006) through preferential activation of DNA 
damage checkpoint and repair, which involves Chk1 and Chk2 proteins as was described 
for the CD133+ cell population in gliomas (Bao et al., 2006). It has been also reported an 
increase of CD44+CD24–/low cell population in breast cancer cell line MCF7 after short 
courses of fractionated irradiation (Phillips et al., 2006).  In sum, it is extremely important 
to identify and understand these mechanisms and to design new therapeutic strategies to 
target this cancer cell population.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – Schematic representation of the clonal model and cancer stem model. (A) The cancer 
stem model, where only a subpopulation of cells within a neoplasia is tumorigenic and harbours the 
potential to differentiate into several cell types, which is reflected in tumour heterogeneity. (B) 
Represents the clonal model, where any cell can receive an oncogenic hit, originating mutant 
tumour cells with growth advantage, that are selected and expanded through additional mutations, 
epigenetic events and microenvironment modulation. 
Adapted from: Vieira, AF. (2012)  
A B 
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4. DNA Damage response and repair pathway (focus on the role of proteins 
in study and damage caused by the agents used in our work) 
 
Cells are constantly exposed to a wide range of genotoxic insults arising from both 
endogenous and exogenous factors, leading to the disruption the of DNA integrity. These 
insults can be provided by chemical reactions, such as reactive oxygen species (ROS) 
generated by cellular metabolism or insults induced by the surrounding environment. 
Consistent with the wide diversity of potential DNA lesions agents, eukaryotic cells 
exhibit many highly conserved DNA repair mechanisms that can recognize and repair 
different types of DNA damage, with varying fidelity and mutagenic consequences, in an 
attempt to maintain  genomic integrity and stability (Blanpain et al., 2011; Hoeijmakers, 
2009). Besides the repair mechanisms, cells can activate the apoptotic or senescence 
pathways (Campisi and d'Adda di Fagagna, 2007).  
However, many questions remain about how and which proteins are in fact 
involved in these pathways. It is known that each type of DNA assault results in a different 
type of lesion, which can be repaired with different fidelities by a distinct and highly 
restricted pool of proteins and crosstalk of pathways. These can be accomplished directly 
or indirectly through post-translational modifications, like phosphorylation and 
ubiquitination, that modulate the DNA damage response in a spatial and temporal manner 
and cell cycle-dependent regulation, playing a key role in the regulation of both DNA 
repair and checkpoint activation (Warmerdam and Kanaar, 2010; Cimprich and Cortez, 
2008).  
The DDR/R machinery encompasses a signalling cascade of proteins activation by 
phosphorylation, classified according to their position and function in the pathway, namely 
as sensors and mediators of DNA damage, signal transducers, and effectors (Sancar et 
al., 2004). Ataxia-telangiectasia mutated (ATM) and Rad3-related (ATR) are the apical 
kinases that recognize DSBs induced by ionizing radiation and SSBs provided by UV light, 
respectively (Shiloh, 2001). These are protein sensors that, when DNA damage occurs, 
activate a cascade of downstream proteins, mainly checkpoint kinase Chk2 and Chk1, 
respectively but not exclusively. It has been reported phosphorylation of Chk2 by ATR and 
Chk1 by ATM (Figure 5). Checkpoints have been identified at the G1/S, G2/M and S 
phases, which result from multiple, often redundant, signalling pathways that converge on 
key decision-making factors, such as p53 and the cell-division cycle 25 (CDC25) 
phosphatases. DNA-damage-induced CDC25 inactivation causes a rapid cell-cycle arrest, 
as these phosphatases are essential for proliferation. By contrast, slower p53 induction 
following phosphorylation by DDR kinases leads to its stabilization and enhancement of its 
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ability to induce the transcription of p21, a cyclin-dependent kinase inhibitor, which results 
in a stable cell-cycle arrest (Sahu et al., 2009; Ouyang et al., 2009; Zeng et al., 1998).   
According to the DNA insult and extension of damage, specific repair pathways are 
activated. Base modifications formed by spontaneous deamination of the DNA, such 
abasic sites, small base adducts induced by ROS from endogenous metabolic reactions, 
as the ones induced by H2O2 or exogenous origin like ionising radiation, or alkylation 
products and SSBs induced by UV light, are all repaired by base excision repair (BER) 
pathway. The damage recognition and releasing of the target base begins by the DNA 
glycosylate, originating abasic sites that are removed by AP endonuclease 1 (APE1), 
creating a nick. The insertion of the first nucleotide is made by DNA polymerase β and, 
subsequently, one of the following sub-pathways are activated: the short–patch, which 
involve the replacement of one single nucleotide, where poly(ADP-ribose) polymerase 1 
and 2 (PARP1 and PARP2) act as sensors and signal transducers, or the long-patch, 
which mediate the replacement of up to  2 nucleotides, with aid of proliferating nuclear cell 
antigen (PCNA), X-ray complementing 1 (XRCC1), among other proteins intervention 
(d'Adda di Fagagna, 2008; Christmann et al., 2003; Liu et al., 2007).  
Nucleotide modifications induced by UV light, specifically cyclobutane pyrimidine 
dimers (CPDs) and 6-4 pyrimidine-pyrimidone photoproducts (6-4PPs), and bulky DNA 
adducts induced by chemotherapeutic agents, including cisplatin, for instance, are being 
repaired by nucleotide excision repair (NER) pathway. This pathway operates by two sub-
pathways, global genomic repair (GGR) and transcription-coupled repair (TCR), which 
differ only in the step involving recognition of the DNA lesion. Following recognition of the 
damage, the sub-pathways then converge for the incision/excision steps and subsequent 
gap filling and ligation steps. The GGR remove lesion genome-wide, whereas TCR 
removes lesions specifically from the transcribed strands of actively transcribing genes 
(Shuck et al., 2008; Hanasoge and Ljungman, 2007).  The GGR is initiated by the 
activation of several DNA-damage binding proteins, most importantly the XPC-HR23B 
centrin-2 complex and/or the DDB1-DDB2 (DNA damage binding protein 1 and 2) 
heterodimer complex. In contrast, TCR sub-pathway involves the RNA polymerase II,  
Cockayne Syndrome protein B (CSB) and the WD40 domain containing protein Cockayne 
Syndrome protein A (CSA). Common set of NER proteins involves the unwinding of the 
DNA duplex at the sites of damage by Xeroderma Pigmentosum group B and D helicases 
(XPB and XPD). XPA is then recruited to stabilize the repair complex and to orient the 
dual incision of the DNA lesion by two structure-specific endonucleases, XPG and 
ERCC1-XPF, leading to the removal of a section of single stranded DNA with a gap of 25–
30 nucleotides. This gap is then filled by DNA synthesis and ligation via DNA polymerase 
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δ /ε, replication factor C (RFC), PCNA, RPA and DNA ligase I (Shuck et al., 2008; Farrell 
et al., 2011).  
DNA double strand breaks (DSBs) are the type of lesions which are highly lethal 
by DNA damage. The DSBs origin is wide. Some agents create DSBs directly, as ionising 
radiation (IR), or some chemotherapeutic drugs, as bleomycin, neocarzinostatin and 
hydroxyurea, whereas others create various types of non-DSB DNA and cellular damage 
that can lead to DSB formation during attempted repair. These lesions can be repaired by 
two pathways, according to the cell cycle state, the homologous recombination (HR) or 
non-homologous end-joining recombination (NHEJ) pathway. The first pathway occurs 
during the late S and G2 phases. In contrast, the second pathway occurs essentially 
during the G0 and G1 phases. The HR uses as template the sister chromatid or even the 
homologue chromosome, avoiding the occurrence of errors during the DNA repair. To 
accomplish the repair, this pathway require the BRCA1, BRCA2 and RAD51 complex of 
proteins. In contrast, the (NHEJ) pathway comprise the religation of the broken strands 
without require the homologue template, which can lead to the formation of errors, hence 
is classified as error-prone. In this pathway, participates the Ku-70 and Ku-80 complex 
that associates with the catalytic subunit of DNA protein kinase (DNA-PK). The XRCC4 
then is phosphorylated by the DNA-PK and forms a complex with the DNA ligase IV that 
usually associates with MRE11-Rad50-NBS1 complex (Christmann et al., 2003; Bonner et 
al., 2008; Bouwman and Jonkers, 2012).  
A key component in DSBs repair is the core histone H2AX, a member of the 
histone H2A family, one of the five families of histones that package and organize 
eukaryotic DNA into chromatin. This protein is phosphorylated at Ser139 by ATM, ATR 
and DNA-PK upstream kinases, in response to DNA DSBs (Burma et al., 2001). The 
formation of γH2AX nuclear foci on DSBs sites is the earliest event and the major signal 
for recruitment of DNA-damage-response proteins to regions of damaged chromatin (Paull 
et al., 2000). Moreover, H2AX phosphorylation patterns have been implicated to 
determine whether cells repair the damaged DNA to survive or undergo apoptosis, 
although precise mechanisms that determinate the cell fate decision remains poorly 
understood (Cook et al., 2009; Burma et al., 2001). Additionally, it has been reported that 
monitoring DSB responses through γH2AX formation has an excellent potential for 
determination of the therapeutic progress and cancer progression (Bonner et al., 2008). 
 Mutations in genes encoding many proteins above mentioned lead to the 
development of syndromes and cancer. Inherited mutations of the BRCA1 confer an 
increased risk for breast cancer among other neoplasias. BRCA1 has been involved in 
various pathways of DDR machinery, such as DNA damage signalling and repair, 
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regulation of cell cycle progression, and maintenance of genome integrity (Ouchi, 2006). 
Additionally, Xeroderma Pigmentosum (XP), which causes defects in proteins involved in 
the NER, induces photosensitivity, increasing the risk to develop skin cancer 
(Hoeijmakers, 2009); mutations in ATR and ATM causes Ataxia telangiectasia (A-T) 
(Louis–Bar syndrome) and Seckel syndrome, respectively. Besides neurodegeneration 
conditions, Ataxia telangiectasia increases the risk to develop cancer. Interestingly, it has 
been reported that the loss of one allele increases 2 fold the risk to develop breast cancer 
in women (Thompson et al., 2005; Renwick et al., 2006; O'Driscoll et al., 2003).  
Moreover, mutations in CHK2 increases 2-3% the risk to develop breast cancer (Meijers-
Heijboer et al., 2002)   
In the malignant context, understanding how these pathways work might be 
extremely useful to design new therapeutic approaches, as synthetic lethality (Dietlein et 
al., 2014). One example is the use of PARP1 inhibitors, as Iniparib or Olaparib, in 
combination with chemotherapy in BRCA-1 and BRCA-2 defective breast carcinomas. 
The combination showed improvement in overall survival and progression-free survival in 
a phase II trial in tripe-negative breast cancer (O'Shaughnessy et al., 2011; Dietlein et al., 
2014). Additionally, others studies reported potential efficacy of small molecule inhibitors 
of ATR in combination with DNA cross-linking agents (Llona-Minguez et al., 2014) and 
Chk1 as a therapeutic target in triple negative breast cancer (Albiges et al., 2014). 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 - Simplified scheme of DNA damage signalling. 
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II.HYPOTHESIS AND AIMS 
 
 
Previous results have shown that P-cadherin expression confers stem cells 
properties to triple negative breast cancer cells, such as enhanced in vitro self-renew 
capacity and anoikis-resistance, as well as in vivo tumorigenic capacity. Furthermore, we 
have previously demonstrated that P-cadherin expression still confers increased 
resistance to X-ray induced cell death. However, the molecular mechanism involved in the 
P-cadherin mediated cell-death resistance and/or cell survival of cancer cells is still not 
known. 
According to this preliminary data, we hypothesise that P-cadherin mediates a 
cancer stem cell survival phenotype that confers resistance to cell death, probably via 
modulation of the DNA damage response and repair pathway. Thus, in this work, we 
exposed normal and cancer cells to DNA damaging agents, as well as to cell death 
inducing stimuli, in order to test the effect of P-cadherin expression in the cellular 
response to these treatments. To achieve that, the following specific aims have been 
designed:  
 
1. To evaluate the activation of the DNA-damage response (Chk1 and Chk2) and 
DNA repair pathways (уH2AX) in response to different stimuli, namely H2O2, UV-C 
radiation and Taxol, in normal MCF10A breast cells and BT-20 breast cancer cells. 
 
2. To study the effect of P-cadherin manipulation in the DNA damage response and 
DNA repair pathways (DDR/R) in response to the different stimuli previously 
described, comparing normal MCF10A breast cells and BT-20 breast cancer cells. 
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III. MATERIAL AND METHODS 
 
 
Cell lines Culture 
The cell lines used in the work were MCF10A, which is a normal-like breast cell 
line, and BT-20, a basal-like breast cancer cell line, both obtained from ATCC (American 
Type Culture Collection, Manassas, VA). MCF10A growth media was composed by 
DMEM:F12 (Invitrogen, Carlsbad, CA), supplemented with heat inactivated horse serum 
(Invitrogen), 10 µg/mL insulin (Sigma-Aldrich, St Louis, MO), 0,5 µg/mL hydrocortisone 
(Sigma-Aldrich) and 20 ng/ml epidermal growth factor (EGF) (Sigma-Aldrich) and 1% 
penicillin- streptomycin (Invitrogen). 
BT-20 cells were cultured in DMEM (Invitrogen) supplemented with 10% foetal 
bovine serum (FBS, Invitrogen) and 1% penicillin- streptomycin (Invitrogen). Both cell 
lines were cultured in a humidified atmosphere with 5% CO2 at 37ºC. 
 
Cell Culture Treatments  
 Cells lines grown in monolayer were subjected to CDH3 gene silencing according 
to the protocol described above and 48 hours after transfection, the cells were exposed to 
different stimuli in cell culture medium without FBS: 
 
 
 
 
 
 
 
 
 Hydrogen peroxide (H2O2) was given at a concentration of 500µM for 30 
minutes; 
 UV light was irradiated for 30 minutes (34.2mW/cm2), and a recovery time 
of 15 minutes was performed in the incubator, before proceeding with the 
experiment; 
Figure 6 - Scheme indicating the DNA stress-
inducing stimuli used and the time of the 
exposure in MCF10A and BT-20 cell lines. 
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 Taxol was given at a concentration of 50nM for 4 hours. DMSO was used 
as a vehicle, so control samples treated with this solvent have been also 
tested. 
 
P-Cadherin/CDH3 SiRNA knock-down  
P-cadherin (CDH3 gene) expression was silenced using the siRNA target 
sequence: AAGCCTCTTACCTGCCGTAAA in a final concentration of 2 nM siRNA 
(Qiagen) using HiPerFect transfection reagent (Qiagen, Hilden, Germany), according to 
manufacturer instructions and siRNA scrambled sequence was included as a control 
(Qiagen). 
 
Cell cycle Assay 
The cell cycle was studied to evaluate the effect of the above-mentioned stimuli on 
cell cycle profile by flow cytometry. 
 For the cell cycle profile analysis, cells were treated according to the conditions 
described on the section Cell Culture Treatments. Then, the medium was removed and 
replaced by a new medium containing serum (Figure 7). The cell cycle analyses were 
performed according to the procedures described below.   
 
 
 
 
 
 
 
 
Cells were grown in monolayer and, 24 hours after, were washed 2 times with PBS 
and detached using trypsin enzymatic digestion (Invitrogen) for 5 minutes, 37ºC. Then, 3 
ml of cold absolute ethanol (Merck, Darmstadt, Germany) was added to 1 ml of cell 
suspension and the cells were fixed for at least 1h at 4ºC. After washing the cells with 
PBS, the propidium iodide (Sigma-Aldrich) solution, containing RNase A 10µg/ml 
(worthington biochemicals), was added and incubated for 15 minutes at 4ºC. Cells were 
Figure 7 - Scheme representation of the cell lines 
treatments until the study of the cell cycle. 
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analysed for cell cycle fluorescence in BD Accuri™ C6. The data was analysed using a 
BD Accuri™ C6 software.  
Apoptosis Assay 
To perform the cytometry evaluation of the apoptosis in cell lines silenced with 
CDH3 expression and treated according to the procedures described on the section Cell 
Culture and Treatments (Figure 8), an Annexin V-FITC Apoptosis Detection Kit I (Abcam) 
was used, according to the manufacturer’s protocol.   
 
 
 
 
 
 
 
 
Cells were left grown in monolayer and, 24 hours after the treatments, were 
washed 2 times in PBS and detached using trypsin enzymatic digestion (Invitrogen) for 5 
minutes, 37ºC. Then, cells were resuspended in buffer 1x and after adding propidium 
iodide (PI) and Annexin V-FITC, the samples were incubated at 4ºC for 20 minutes in the 
dark. 
In order to set the gating strategy, the following control samples were also 
prepared: unstained sample, with no addition of PI or annexin V-FITC antibody; PI single 
stain sample, with the addition of only PI to the sample; FITC single stain, with the a 
addition of only the annexin V-FITC to the sample.  
Cells were analysed in BD Accuri™ C6 and the data was analysed using the BD 
Accuri™ C6 software. 
 
 
 
 
 
 
 
Figure 8 - Scheme representation of the cell lines 
treatments until the study of the apoptosis. 
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Mammosphere Assay 
Upon the cell treatments according to the Cell Culture Treatments section were 
performed the mammosphere assay (Figure 9). 
 
 
 
 
 
Mammosphere assay was used to measure stem cell activity. 
 Cell lines were harvested with Trypsin (Invitrogen). Then, these cells were passed 
through a 25 gauge-needle for dissociation into single cell suspension, plated at 750 or 
500 cells/cm2  density (MCF10A and BT-20, respectively)   in a medium pro anoikis 
composed by DMEM/F12 (phenol red free) containing B27 supplement (Invitrogen), 500 
ng/ml hydrocortisone (Sigma-Aldrich), 40 ng/ml insulin (Sigma-Aldrich), 20 ng/ml EGF 
(Sigma-Aldrich). These were maintained in a humidified incubator at 37°C and 5% (v/v) 
CO2, in a plate previously coated with 1.2% poly(2-hydroxyethylmethacrylate)/95%ethanol 
(Sigma-Aldrich) and left to grow for 5 days. Mammosphere forming efficiency (MFE) was 
calculated as the number of mammosphere formed, ≥ 75 µm determined using an 
eyepiece graticule with crossed scales, divided by the number of cell plated, expressed as 
a percentage. 
 
Comet assay-Single-cell gel electrophoresis  
  The comet assay is a sensitive and reliable method that enables to measure DNA 
damage induced by a wide range of genotoxic agents, as H2O2 or UV irradiation at the 
cellular level. It was described for the first time by Ostling and Johanson, and was 
performed under neutral pH conditions (Ostling and Johanson, 1984). Subsequently, the 
protocol suffered alterations and becoming performed under alkaline pH conditions (Singh 
et al., 1988), which remains in its most commonly used form. Variants of the comet assay 
protocol have been proposed for measuring different forms of DNA damage, such as 
single strand breaks, alkali-labile sites (Singh et al., 1988), double strand breaks(Olive et 
al., 1991) as well as DNA cross-links (Pfuhler and Wolf, 1996). 
The principle of this method is based in the ability of migration of the DNA 
fragmented, during the electrophoresis, forming the comet-shaped structure. In contrast, 
Figure 9- Scheme representation of the cell lines 
treatments until the mammosphere assay 
proceedings  
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the DNA undamaged with high molecular weight and without free ends, remains unable to 
move, depicting a nuclei (Olive et al., 1990).  
The protocol encompass the following steps: upon cellular exposure to a DNA- 
damage agent, cells are embedded in agarose, lysed, subjected to a brief electrophoresis 
and stained (Figure 10). 
Comets can be visualized using the fluorescent microscopy and the staining is 
performed with a DNA-binding dye, usually, ethidium propidium (EP), or propidium iodide 
(PI). Some protocols use SYBR-green, but this is a stain solution more instable 
comparatively with EP or PI, being used preferentially one of the aforementioned (Bauch 
et al., 1999).  
To quantify the level of DNA damage, the comet size, shape and the amount of 
DNA within it needs to be measured. The extent of DNA damage is related to the amount 
of DNA in the tail. Comets could be categorised according to the size of the head (nuclei) 
and the length and intensity of the tail, to a qualitatively quantification, performed usually 
by visual inspection. The quantitative analyse involves the use of image analyses 
software, allowing quantify a larger number of comets more rapidly and avoid the human 
subjectivity (Gyori et al., 2014; Driessens et al., 2009; Benhusein et al., 2010; Olive and 
Banath, 2006).  
DNA percentage in tail, tail moment and Olive moment are the measures of DNA 
damage that have been shown to be particularly good indicators of the underlying 
damage, although the choice still in debate.  Here, we used the tail moment that enables 
measure the tail length times the percentage of DNA within, using the Open Comet tool. 
This software is a plug-in for the ImageJ, allowing detect the comets automatically. The 
comet measurements and statistics are exported as a spreadsheet to the Excel (Gyori et 
al., 2014).  
Here, we performed the alkaline comet assay to measure the extent of single and 
double strand breaks in the DNA, according the procedures below described and 
according to the (Figure 10). 
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Cells were exposed to the DNA stress-inducing stimuli according to the Cell 
culture Treatments section (Figure 11), and the comet assay was performed, according to 
the following proceedings.  
 
 
 
 
 
 
 
Cells were trypsinized, collected to an Eppendorf and centrifuged at 4ºC 1200 rpm. 
The supernatants were removed and the cells resuspended in agarose low melting point 
(Sigma-Aldrich). Then, the volume containing 100 cells/µl was dispensed in a microscope 
slide previously coated with agarose normal melting point (Sigma - Aldrich) and allowed to 
dry for about 10 minutes at 4ºC. The lysis were performed overnight at 4ºC and the 
electrophoresis was performed for 20 minutes at 30 mV in a solution of 300mM NaOH, 
1mM disodium EDTA, pH 13. Then the slides were immersed for 15 minutes in ethanol 
70% and 90% and left to dry at room temperature. The coloration was performed by PI 
and visualized in a Zeiss microscope. Photos were taken an x20 magnification and 
OpenComet tool was used to perform the quantification.  
 
 
 
Figure 11 - Scheme representation of the cell 
lines treatments to perform the comet assay. 
.   Figure 10 - Schematic representation of the comet assay proceedings.  
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Immunocytochemistry  
Cell lines were seeded on top of glass coverslips, treated according to the section 
Cell Culture and Treatments (Figure 12) and immediately fixed with 4% 
paraformaldehyde, permeabilized with 0.1% Triton X-100 and blocked with 2% BSA. 
Staining was performed using the уH2AX (1:500, Millipore) primary antibody and anti-
mouse Alexa 488 (1:500, Invitrogen) secondary antibody.  
 
 
 
 
 
 
 
Slides were stained with in 4',6-diamidino-2-phenylindole (DAPI) and visualized using a 
Zeiss Imager Z.1 microscope (Zeiss, Welwyn Garden City, UK). An x40 magnification oil 
immersion objective was employed for scoring foci. Photos were taken using Z-stack 
mode. Foci were scored in 100 cell nuclei per sample.  The different patterns of the 
уH2AX staining could be observed in the (Figure 13).  Based on уH2AX foci in untreated 
BT-20 cell line, we considered as уH2AX positive to DNA damage when presented at 
least 3 foci per nuclei.   
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
Figure 12 - Scheme representation of the cell lines 
treatments to perform the уH2AX foci evaluation 
Figure 13 - Photographic representation of the different patterns 
of staining of the уH2AX. Photos were taken from BT-20 cell line 
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Immunoblot analysis 
 
Upon the treatments described on the section Cell Culture and Treatments (Figure 
14), cells were lysed by a solution composed by HEPES, NaPP, NaCl, NaF, Triton X-100, 
glycerol and EDTA that contains a protease inhibitors cocktail (Roche Diagnostics Gmbh, 
Mannheim, Germany) and a phosphatase inhibitors cocktail (Sigma-Aldrich).  
 
 
 
 
 
 
Protein concentration was determined by Bio-Rad protein assay (Bio-Rad, 
Richmond, CA) and equal amounts were resolved on a denaturation polyacrylamide gel 
(Bio-Rad) and transferred onto a nitrocellulose membrane (Amersham Pharmacia 
Biotech, Piscataway, NJ). After blocking nonspecific binding with 5% non-fat dry milk in 
PBS containing 0.5% Tween 20 (Sigma-Aldrich), each membrane was incubated 
overnight with the following primary antibodies:  anti-P-cadherin (1:500, BD Transduction), 
anti-Chk1 ( 1:1000, Cell Signaling), anti- Phospho-Chk1 (Ser317) ( 1:500, Cell signaling),  
anti-Chk2 (1:1000, Cell Signaling), anti- Phospho-Chk2 (Tyh 68) (1:500, Cell Signaling), 
уH2AX (1:500, Millipore), anti- Phospho-ATM (S1981) (1:500, Cell Signalling), anti-
Phospho-BRCA1(S1524) (1:1000, Cell Signalling). GAPDH (1:10 000, Santa Cruz) was 
used as loading control.  
After washing four times with PBS Tween 0, 5% for 5 minutes, the membranes 
were incubated with peroxidase-conjugated secondary antibodies from Santa Cruz 
Biotechnology (1:2000) for 45 minutes and washed six times for 5 minutes. Detection was 
performed using the Amersham Hyperfilm and Amersham ECL Detection substrate (GE 
Healthcare, Chalfont St. Giles, UK). 
Quantification was performed using an ImageJ 1.49f software.  
 
 
 
 
 
Figure 14 - Scheme representation of the cell 
lines treatments to perform the Immunoblot 
analysis. 
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Statistical Analysis 
 
A confidence level of 95% was considered to evaluate statistical significant 
differences between conditions and the following statistical tests were applied: two-tailed 
unpaired t test for Mammosphere forming efficiency (MFE), Mann-Whitney U test for the 
western blotting and comet assay.  Statistical analyses were carried out using GraphPad 
Prism 6.04 software. 
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V.RESULTS 
  
i. Evaluation of cellular response to different DNA stress-inducing agents of 
mammary normal-like cells and in breast cancer cells  
 
In the first part of this work, three different DNA stress-inducing agents were 
employed to characterize and compare the responsive behavior of normal breast cells 
(MCF10A) and breast cancer cells (BT-20) regarding cell cycle, apoptosis, stem cell 
activity and DNA damage activation of DDR/R pathway.  The agents used were hydrogen 
peroxide (H2O2), which induces an excess of cellular ROS levels, UV-C irradiation that 
causes DNA adducts formation, and Taxol, which is an apoptotic inducer, microtubule 
stabilizer and a metaphase blocker of the cell cycle. 
In the second part of this work, the effect of P-cadherin expression in the cellular 
response to these distinct stimuli has been tested. The same cell lines have been used to 
compare its effect in the normal and cancer context and the same parameters have been 
evaluated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44 
 
Cell cycle profile  
 
To evaluate the effect of DNA insults in the cell cycle, flow cytometry has been 
performed with propidium iodide (PI) stain.   
The graphs depicted below translate the cell cycle profile of MCF10A and BT-20, 
after being exposed to hydrogen peroxide (H2O2), UV light (UV) and Taxol, in the doses 
and time points stated in the Materials and Methods section. Clearly, in both cell lines, the 
UV light and Taxol increased the percentage of the cells in Sub G1 phase comparatively 
to control cells (data not shown).  
Examining the relative height of the G1 and the G2M peaks, it is possible to see 
that H2O2 doesn’t seem to have an effect in the MCF10A cell line, but increases G2M 
phase in BT-20 cell line, in relation to control/DMSO treated cells (Figure 15).   
The treatment with Taxol increases the number of cells in the G2M phase of cell 
cycle in both cell lines (Figure 15).  
The number of live cells in the treatment with UV light was very low, which did not 
allow the evaluation of the effect of this stimulus in the cell cycle. More events need to be 
acquired in order to take clear conclusions (Figure 15).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
MCF10A 
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Induction of Apoptosis  
 
To evaluate the extension of cell death and apoptosis induced by H2O2, UV light and 
Taxol, 24 hours after the exposure to different type of DNA stress-inducing stimuli PI 
/Annexin V assay by flow cytometry has been performed. We considered dead cells when 
they were positive for both PI and annexin V stain; we considered apoptotic cells, when 
they stained for annexin V only. 
 As we can observe in the  Figure 16, UV light was the DNA stress-inducing stimuli 
that more cell death and apoptosis caused (98.05% and 89.99%, MCF10A and BT-20, 
respectively), in agreement with the results previously obtained for the sub-G1 phase 
analysis described previously. Following the UV light, the stimuli that caused more 
dead/apoptotic cells were the taxol (50.42% and 41.63%, MCF10A and BT-20, 
respectively) and H2O2 (41.28% and 20.19%, MCF10A and BT-20, respectively). 
Curiously, in BT-20 cell line, after exposure to H2O2, appears that this stimuli has no 
additive effect concerning cell death and apoptosis comparatively to control cell (NT) 
(Figure 16 B). 
 
A 
Figure 15 - Evaluation of (A) MCF10A and (B) BT-20 cell cycle profile 24 hours after of exposure 
to DNA stress-inducing insults, namely, hydrogen peroxide (H2O2), UV light (UV) and Taxol, of one 
experiment. DMSO was used as vehicle of Taxol.  
B 
BT-20 
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Stem cell activity 
 
To evaluate the influence of H2O2, UV light and taxol in stem cell activity of the 
MCF10A and BT-20 cell lines the mammosphere assay was performed. This assay is 
based in the capacity that stem cells have to survive in anoikis-induced conditions, 
whereas non-stem cells die by this apoptotic process. The results showed that the H2O2 
decreased significantly the formation of mammospheres in both cell lines (p=0.03 and 
p=0.02, unpaired test, MCF10A and BT-20, respectively). The taxol only decreased 
significantly the formation of mammospheres in BT-20 cell line (p=0.00) and the 
exposition of UV light abolished breast cancer stem cells sphere formation (Figure 17) in 
both cell lines. Moreover, it was observed alterations concerning to morphology.  
Treatment with H2O2 and taxol decreased the size of the mammospheres and the 
mammospheres became loose comparatively to the compact spherical structure of 
mammospheres of untreated (NT) or vehicle (DMSO) conditions in both cell lines. 
Exposition to UV light prevented the mammosphere formation (Figure 17).  
 
Figure 16 - Percentage of dead and apoptotic cells evaluated by PI (FL3)/Annexin V 
FITC (FL1) flow cytometry staining in (A) MCF10A and (B) BT-20 cell lines, 24 hours 
after treatment with the DNA stress inducing agents of one experiment.  
A 
B 
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Figure 17 – Graph representation of the mammosphere forming efficiency (MFE), expressed 
as % mean ± SEM of at least three independent experiments for (C) MCF10A and (D) BT-20 
cell lines exposed to the DNA stress-inducing stimuli H2O2 and Taxol. Statistical differences 
were evaluated using the unpaired t test. 
B 
A 
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Evaluation of induced DNA damage by the Comet Assay  
 
 
 
 
 
 
C 
 
Figure 18 – Representative images of mammospheres (a) untreated (NT) and treated with (b) 
hydrogen peroxide (H2O2), (c) UV light (UV), (d) vehicle (DMSO) and (e) Taxol in (A) MCF10A cell 
lines and (B) BT-20 cell lines. Scale b r represents 100 µm.  
A   a b c 
d e
e 
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Evaluation of induced DNA damage by the comet assay 
 
To confirm the DNA-damage (single and double-strand breaks) induced by the 
different DNA insults used in this work, the alkaline comet assay was also performed, or 
also denominated by single cell gel electrophoresis, that quantifies DNA damage.  
In this work, as a measure of DNA damage, we used the tail moment parameter 
that enables the measurement of the tail length times tail DNA percentage. The results 
showed that all the DNA stress-inducing stimuli used in our work significantly induced 
DNA damage in both cell lines as compared to controls, untreated (NT) for H2O2 and UV 
and vehicle (DMSO) for Taxol. Interestingly, BT-20 cell line presents higher DNA damage 
comparatively to MCF10A cell line (Figure 19).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H2O2 NT UV 
DMSO Taxol 
C 
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Figure 19 – Graph and photographic representation of two independent experiments of the DNA 
damaged measured by alkaline comet assay in (A;C) MCF10A and  (B;D) BT-20 cell lines treated with 
DNA-stress-inducing insults, namely, hydrogen peroxide (H2O2), UV light (UV) and Taxol. DMSO was 
used as vehicle of Taxol. Were counted at least 50 comets.  Statistical differences were determined by 
Mann-Whitney U test; * means p<.05, ** means p<.01;****means p<.0001.  
B 
NT 
B 
Taxol 
NT 
DMSO 
H2O2 UV D 
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Quantification of the induced DNA damage by immunofluorescence analysis 
of уH2AX foci  
 
To evaluate the extent of DNA damage after the different treatments with DNA 
stressful insults, immunofluorescence microscopy was used to access the expression of 
DNA DSBs marker- the уH2AX marker. 
Based on the quantification of the number of уH2AX foci. We could clearly observe 
that MCF10A was more sensible to H2O2 than BT-20 cells. BT-20 cells showed more DNA 
damage to UV than MCF10A cells. We observed that the action of DNA stress-inducing 
agent’s sensibility were cell type-dependent.  On the other hand, there was no increase of 
DSBs damage in both cell lines when exposed to Taxol comparative to vehicle, which also 
induced DSBs (Figure 20 and Figure 21).  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 20 - Graphical representation of the percentage of уH2AX foci induced by different DNA 
stress agents in (A) MCF10A and (B) BT-20 cell line of one experiment. Was quantified as nuclei 
positive for уH2AX when was detected 3 or more foci in BT-20 cell line. 
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NT 
DMSO Taxol 
UV H2O2 
Figure 21 – Representative images of уH2AX foci in (A) MCF10A and (B) BT-20 cell lines 
untreated (NT) and treated with hydrogen peroxide (H2O2), UV light (UV), vehicle (DMSO) and 
Taxol, as indicated. 
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Western Blots  
 
Upon DNA insults, cells recruit complex molecular machinery involved in DNA 
repair, arrest of cell cycle, and apoptotic pathways, (Hirao et al., 2002; Hirao et al., 2000; 
Jack et al., 2002). 
To evaluate the activation of the DDR pathway in both cell lines, upon treatment 
with H2O2, UV and Taxol, we examined the phosphorylation of two essential checkpoint 
protein kinases, Chk1 and Chk2 on the Ser317 and Thr68 residues, respectively. It was 
observed significant activation of both Chk1 and Chk2 proteins by H2O2 in MCF10A and 
BT-20 cell lines. In MCF10A cell line, incubation with H2O2 activated, more significantly 
the Chk2, whereas, in BT-20 cell line, H2O2 activated, at the same level of confidence, 
both checkpoint protein kinases (Figure 22). Similarly, UV light also activated both 
checkpoint proteins. Interestingly, UV light was the stimulus that more significantly 
induced the Chk1 phosphorylation in normal and breast cancer cell lines, showing 
preferential activation of this particular kinase (Figure 22). Taxol was the stimulus that 
showed the lowest Chk1 and Chk2 phosphorylated forms of these proteins, although there 
was a tendency to increase the pChk1 and pChk2 expression in both cell lines (Figure 
22).  
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Figure 22 – Western-blot analysis and protein quantification of pChk1 and pChk2 proteins, 
normalized to untreated (NT) condition for H2O2 and UV light treatments and vehicle (DMSO) for 
Taxol treatment in (A) MCF10A and (B) BT-20 cell lines. The values are expressed as mean ± 
SEM from at least two experiments shown.  * indicates p< .05, ** indicates p< .005 of Mann-
Whitney U test. Note: DMSO is not represented in blots. 
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ii. The role of P-Cadherin in the DDR/R pathway 
 
The results given by previous studies showed that P-cadherin expression confers 
cellular survival, particularly x-ray cell death resistance. Since the DDR/R pathway is 
tightly connected to the cellular resistance to both chemotherapy and radiotherapy, this 
prompted us to evaluate whether P-cadherin expression has a role in modulating this 
pathway. Thus, to better define this potential interaction we performed the P-cadherin 
knockdown, using siRNA method as aforementioned in MCF10A normal-like and BT-20 
breast cancer cell line and concomitantly these cells were exposed to H2O2, UV light and 
taxol in doses and time points described in material and methods.  
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Cell cycle profile  
 
To evaluate the role of P-cadherin in the cell cycle profile, the downregulation of 
the CDH3 gene was performed using the siRNA and the DNA stress-inducing insults were 
administered 48h after transfection. Next, 24 h after the treatments the cell cycle was 
evaluated by flow cytometry. We observed no effect of P-cadherin silencing alone or in 
combination with treatments on the cell cycle profile (Figure 23). These results indicate 
that P-cadherin expression has no influence in the cell cycle profile at the time points and 
treatment conditions given in both cell lines.  
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Figure 23 – Flow cytometric evaluation of the cell cycle profile in (A) MCF10A cells and (B) 
BT-20 cells after silencing of P-cadherin/CDH3 expression and after 24 hours of exposure to 
DNA stress-inducing agents of one experiment. Blue line – siRNA scramble, red line – siRNA 
CDH3/P-cadherin. * These graphs were depicted by Flowjo software.  
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Induction of Apoptosis  
 
To study the role of P-cadherin in cell death, PI/Annexin V assay was performed 
by flow cytometry. Cell death was increased in MCF10A cell line when P-cadherin was 
silenced alone, being incremented by the association with exposure to H2O2 and Taxol. 
This tendency was also maintained in the BT-20 cell line. The treatment with UV caused 
extensive cell death for both conditions, in cells silenced and not silenced to P-cadherin, 
hiding the potential differences (Figure 24).    
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Figure 24 - Percentage of dead and apoptotic cells evaluated by PI/Annexin V FITC 
flow cytometry staining in (A) MCF10A and (B) BT-20 cell lines, 24 hours after 
treatment with the DNA stress inducing agents of one experiment.   
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Stem cell activity  
 
With the purpose to uncover the role of P-cadherin alone and in combination with 
DNA stress-inducing stimuli in the stem cell activity, we measured the survival of stem 
cells by the mammosphere assay. 
We found that P-cadherin downregulation alone decreases the mammosphere 
efficiency (Figure 25). This effect was incremented when H2O2 was added in both cell 
lines, normal-like and breast cancer cell line. Moreover, we observed a similar additional 
effect in mammosphere forming efficiency when BT-20 cell line was treated with Taxol 
and P-cadherin was silenced (p=0.03). The same was not observed for the MCF10A 
normal-like cell line, although the tendency to decrease of mammosphere forming 
efficiency is maintained. These results demonstrate that taxol is a DNA stress-inducing 
stimulus that affect stem cell activity in cell type-dependent way.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25  – Graph representation of the mammosphere forming efficiency (MFE), expressed as % 
mean ± SEM of at least three independent experiments for (A) MCF10A and (B) BT-20 cell lines 
exposed to DNA stress- inducing stimuli in study. DMSO was used as vehicle of Taxol. 
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Evaluation of induced DNA damage by the Comet Assay  
 
To study the role of P-cadherin in DNA damage resistance, its downregulation by 
siRNA method was performed and cells were exposed to the distinct stress-inducing 
stimuli. The DNA damage was measured by alkaline comet assay and quantified by the 
tail moment parameter.  
The downregulation of P-cadherin alone sensitized both cell lines to DNA damage, 
which reflects the tendency to have increased DNA damage in MCF10A cell line and the 
significantly elevated DNA damage in BT-20 cell line (p=0.00, Mann-Whitney test). The 
treatment with H2O2 increased significantly the tail moment (p= 0.00; p < 0.0001, MCF10A 
and BT-20, respectively). The same tendency was significantly observed with UV 
irradiation (p= 0.03, p < 0.0001, MCF10A and BT-20, respectively), although to a higher 
extension in the BT-20 cell line. Furthermore, this DNA damage was significantly 
incremented by downregulation of P-cadherin in both cell lines (p= 0.00; p < 0.0001, 
MCF10A and BT-20 incubated with H2O2) (p < 0.0001; p=0.00; MCF10A and BT-20, 
irradiated by UV light). The treatment with taxol induced significant increase in DNA 
damage in BT-20 cell line (p < 0.0001) and with tendency to increase DNA damage in 
MCF10A cell line. P-cadherin silencing incremented the DNA insults after treatment of 
taxol for both cell lines, although only significantly (p < 0.0001) for the MCF10A cell line 
(Figure 26). 
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Figure 26 – Graphical representation of DNA damaged measured by alkaline comet assay in 
(A) MCF10A and  (B) BT-20 cell lines silenced to CDH3/P-cadherin and  treated with DNA-
stress-inducing insults, namely, hydrogen peroxide (H2O2), UV light (UV), Taxol. DMSO was 
used as vehicle of Taxol. Statistical diferences were determined by Mann-Whitney U test; ** 
means p<.005; *** means p<.001; ****means p<.0001. 
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Quantification of the induced DNA damage by immunofluorescence analysis 
of уH2AX foci  
 
To undercover the role of P-cadherin in the DNA damage, the downregulation of 
this gene was performed and the DNA damage induced by H2O2, UV and Taxol was 
evaluated by уH2AX quantification. In both cell lines, MCF10A and BT-20, the treatment 
with H2O2 and UV light induced double strand breaks as shown by an increase in the 
percentage of уH2AX positive cells. The percentage of damage induced by H2O2 was 
higher in the normal cell line MCF10A, than in the cancer cell line BT-20. In non-treated 
cells, when P-cadherin was silenced the percentage of cells with DNA damage 
significantly increased in both MCF10A and BT-20 cells, although to a lower extension in 
the cancer cells. Importantly, in  cells treated with DNA insults, the percentage of уH2AX 
positive cells further increased after P-cadherin silencing, with a pronounced effect for 
H2O2 and UV light in the BT-20 cell line, and for UV light in the normal cell line MCF10A 
(Figure 27).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 - Graphical representation of the percentage of уH2AX nuclear foci induced by different 
DNA stress agents and siRNA CDH3/P-cadherin in (A) MCF10A and (B) BT-20 cell lines. The 
graphs represents one experiment.  
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Western blots  
 
In MCF10A cell line, the siRNA P-cadherin showed a significant (p=0.02) increase 
of the phosphorylated Chk2. Although, not statistically significant, this tendency was 
maintained concerning pChk1. In BT-20 cell line, the silencing of P-cadherin expression 
induced a tendency to increase the expression of pChk1, as observed in normal-like cell 
line (Figure 28 A,C). The additional treatment with H2O2 does not significantly affected the 
pChk1 and pChk2 expression, but showed a tendency to increase these proteins in 
MCF10A cell line. In BT-20 cell line, exposition to H2O2 and downregulation of P-cadherin 
induced a tendency to decrease the expression of pChk1 and no differences were 
observed concerning pChk2 (Figure 28 A).  
UV irradiation with P-cadherin silencing increased the pChk1 and pChk2, in BT20 
cell line. In MCF10A cell line also showed a tendency to increase the pChk1, but 
decreased the pChk2 (Figure 28 A, B). 
 Incubation with Taxol in combination with silencing of P-cadherin, showed a 
tendency to increase the pChk1 and decrease the pChk2 in BT20 cells. A tendency for 
decrease of pChk2 was also observed in MCF10A cell line (Figure 28 A, B). 
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Figure 28 – Western-blot and protein quantification of pChk1 and pChk2 proteins 
normalized to GAPDH and presented in relation to untreated (NT) condition for H2O2 and 
UV light treatments and vehicle (DMSO) for Taxol treatment in (A) MCF10A and (B) BT-20 
cell lines. (C) Western-blot and protein quantification of P-cadherin in MCF10A and BT-20 
cell lines, in DMSO treated and in CDH3/p-cad transfected cells. The values are expressed 
as mean ± SEM from at least two experiments shown.  * indicates p≤ .05, of Mann-Whitney 
U test. (D) Representation of siRNA Scramble and siRNA P-cadherin blot for each cell line, 
as indicated; GAPDH, were used as loading control is also represented. 
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VI.DISCUSSION 
 
 
In the last decade, several studies concerning the biology of cancer stem cells 
have indicated that this cancer cell subpopulation is the responsible for resistance to 
conventional therapies (chemo and radiotherapy), through a wide range of sophisticated 
molecular mechanisms not yet fully elucidated.  
We have previously showed the relevance of P-cadherin as a biomarker that 
enables to isolate breast cancer cells with stem cell properties, but also as a player that 
actively participates in modulating the stem cell activity of basal-like breast cancer cells. In 
particular, we revealed that P-cadherin expression confers cell’s resistance to X-ray-
induced cell death. However, the mechanisms underlying this resistance remain 
completely unknown.  
The DDR/R pathway recruits a complex molecular machinery involved in DNA 
repair, cell cycle arrest, and activation of apoptotic pathways (Jack et al., 2002; Hirao et 
al., 2002; Hirao et al., 2000), when cells are exposed to DNA stress inducing agents. 
Thus, we have designed the present study to test whether the DDR/R pathway could be 
responsible by the resistance to death by cells with high levels of P-cadherin, since this 
signalling path is usually connected to cancer cell resistance to DNA insults provoked by 
standard cancer therapies. For this purpose, we used MCF10A, a normal-like cell line, 
and BT-20, a malignant basal-like breast cancer cell line (Neve et al., 2006), being both 
positive for P-cadherin expression, and investigated the cellular response to different 
types of DNA stress-inducing stimuli before and after P-cadherin silencing.  
Briefly, treatments with three different cell-death inducing agents were performed: 
H2O2, UV light and Taxol.  H2O2 is a well-known inducer of oxidative stress through an 
excessive production of ROS, which cause damage to major cellular components, such as 
proteins, lipids and DNA, inducing mainly single and, in a lower extension, double strand 
breaks (Driessens et al., 2009). Moreover, H2O2 enhances apoptosis or necrosis when in 
excess (Driessens et al., 2009; Thannickal and Fanburg, 2000; d'Adda di Fagagna, 2008). 
UV light is absorbed by nucleic acids and produces several types of nucleotide 
modifications known as photoproducts, specifically cyclobutane pyrimidine dimers (CPDs) 
and 6-4 pyrimidine-pyrimidone photoproducts (6-4PPs), that might be mutagenic or induce 
lethal cellular effects (Nakajima et al., 2004). Finally, Taxol is a microtubule-stabilizing 
taxane that is being clinically used for breast cancer treatment, presenting a distinct 
mechanism of action compared with both aforementioned DNA-stress inducing stimuli. 
This away, Taxol acts as a microtubule-stabilizer and blocks the cell cycle in metaphase, 
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through its ligation to the beta-actin of the microtubules (MTs). The interaction between 
DDR/R pathway and cell cycle checkpoint and the drugs that act via a microtubule-based 
mechanism has not yet been extensively examined. Notwithstanding, a few studies 
suggest an indirect induction of DNA-damage by Taxol (Figure 29)  (Tishler et al., 1995; 
Branham et al., 2004) . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We demonstrated that exposure to H2O2 causes G2/M cell cycle arrest in BT-20 
breast cancer cells, but not in MCF10A normal-like cells. This data can be explained by 
potential differences between the two types of cells in terms of capacity to recover from 
the H2O2 concentration that was used, as also to the differential expression of specific 
checkpoint-associated proteins between both cell lines (Shibata et al., 2011). MCF10A 
cells have intact cell cycle checkpoints and normal proliferation controls (Stan et al., 
2008), whereas BT-20 cell line presents loss of p16, p14, and a p53 missense mutation, 
which possibly contributes to the differences observed on the cell cycle profile in response 
to the administration of H2O2 (Lacroix et al., 2006; Hollestelle et al., 2010; Keimling and 
Wiesmuller, 2009). Moreover, we observed a higher basal Chk1 and Chk2 expression in 
BT-20 compared to MCF10A cell line, which also putatively contributes to cell cycle arrest. 
Although P-cadherin silencing was able to change the expression levels of the checkpoint 
Figure 29 - Scheme simplified of the induced DNA damage by 
the different stimulus used in our work and the potential 
activation of the proteins involved in the DDR/R pathway.  
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proteins, the evaluation of the cell cycle profile showed that P-cadherin siRNA had no 
influence on the different phases of the cell cycle, at the time point tested, which made us 
think that it would be interesting to study the cell cycle in shorter time points. Further, 
these data are in agreement with the ones provided by cell death/apoptosis 
measurements in both cell lines, showing greater cell death in MCF10A cell line 
comparatively to BT-20 cell line when incubated with H2O2, which were further 
incremented by downregulation of P-cadherin expression. This could result from a wild-
type expression of p53 in MCF10A cell lines, leading to activation of p53-dependent cell 
death/apoptosis mechanisms. Here, it would be interesting to study the expression of 
proteins involved in apoptosis to validate this assumption. This data was still supported by 
MFE assay, which showed an increment of cell death when P-cadherin expression was 
downregulated, suggesting a role of P-cadherin in mediating cell-death resistance and 
conferring stem cell properties.  
Based on these results, we could assume that the induction of DNA damage by 
H2O2 administration was probably more extensive in BT-20 than in MCF10A, due to a 
greater sensibility of this cell line to this DNA-stress inducing agent, or due to a higher 
resistance of BT-20 cells to DNA damage. Interestingly, the silencing of P-cadherin 
expression sensitized more extensively the breast cancer cell line to H2O2 DNA damage 
than the normal cell line, as observed by the results obtained by the comet assay and by 
the уH2AX foci quantification.  
One of the most important proteins in the DDR pathway is the core histone H2AX, 
being phosphorylated at Ser139 by ATM, ATR and DNA-PK upstream kinases, in 
response to DNA DSBs (Burma et al., 2001). The formation of уH2AX nuclear foci on 
DSBs sites is the earliest event and the major signal for recruitment of DNA-damage-
response proteins to regions of damaged chromatin (Paull et al., 2000). Moreover, H2AX 
phosphorylation patterns have been implicated to determine whether cells repair the 
damaged DNA to survive or undergo apoptosis, although precisely mechanisms that 
determinate the cell fate decision remains poorly understood (Cook et al., 2009) (Garty et 
al., 2011). We have used immunofluorescence to measure уH2AX foci and monitor the 
DNA DSBs induced by H2O2 at the time point and dose described on the Material and 
Methods section. However, the majority of the reported data indicate that H2O2 induce 
predominantly SSBs, saying however that some of these lesions can be converted, during 
DNA replication, to DNA double-strand breaks (DSBs) (Vilenchik and Knudson, 2003). 
Interestingly, we found that P-cadherin inhibition was able to dramatically increase DSBs 
in MCF10A cells and, to a lower extent, also in BT-20 cell line. However, the MCF10A 
cells were so sensitive to DSBs induced by H2O2, that P-cadherin silencing did not affect 
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the levels of уH2AX; though, BT-20 breast cancer cells treated with H2O2 showed a 
significant increase in уH2AX foci after P-cadherin silencing. These results indicate that P-
cadherin expression renders the cells more resistant to DSBs, showing that its inhibition 
combined with an inducer of oxidative stress can have an important effect in breast cancer 
cells. Notably, the modulation of уH2AX by cell-cell adhesion proteins was already 
previously reported by Kang et al., which showed that intercellular contact stabilizes 
histone H2AX and УH2AX (H2AX phosphorylated on Ser139) by up-regulating N/E-
cadherin and γ-catenin. Downregulation of N-cadherin and y-catenin in HBL100 human 
mammary epithelial cells and in HCT116 human colorectal cancer cells, respectively, 
reduced the levels of H2AX. Despite these results are in contrast with our observations, 
these turn clear the possible crosstalk between DDR pathway and cell adhesion proteins 
(Kang et al., 2012).  
The activation of the DDR and cell cycle checkpoint pathway by the treatment with 
H2O2, was also monitored by phosphorylation of two essential checkpoint protein kinases, 
Chk1 and Chk2 on the Ser317 and Thr68 residues, respectively, known to be 
phosphorylated in response to blocked DNA replication, certain forms of genotoxic stress 
and DNA damage (Zhao and Piwnica-Worms, 2001). As expected, we observed 
significantly activation of both phosphorylated forms of Chk1 and Chk2 in both cell lines, 
indicating the presence of DNA damage (Sahu et al., 2009). Interestingly, it was 
significantly noted higher levels of Chk1 phosphorylation in BT-20 cell line, indicating 
greater sensitivity to H2O2. Curiously, P-cadherin downregulation significantly enhanced 
the phosphorylation of Chk2 in MCF10A cell line and, in contrast, it was observed a slight 
decrease, although not significantly, of pChk2 in BT-20 cell line. A possible interpretation 
of this result is that the potential interaction between cell cycle checkpoint pathway and P-
cadherin may be cell type, or even malignancy state, and Chk2-dependent.   
 Finally, although previous studies reported alterations of cell adhesion proteins 
expression by H2O2 (Cheng et al., 2010; Yu et al., 2012; Rhyu et al., 2005), we could find 
no alterations concerning P-cadherin expression, which can probably be explained by the 
dose and the short time of incubation with this stimulus.  
 
Concerning UV light, it has been reported that induce transient cell cycle arrest at 
different phases of the cell cycle, depending on the dose and cell type used (Gentile et al., 
2003; Gujuluva et al., 1994; Gabrielli et al., 1997; Decraene et al., 2001). Here, we 
observed that the dose and the time point used markedly depicted an uncommon cell 
cycle profile, resulting in high levels of cell death in both cell lines, reflecting also the 
necessity for acquire more events. Thus, the silencing of P-cadherin in combination with 
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this stimulus did not incremented cell cycle alterations, which could be explained by the 
extensive cell death induced, preventing the visualization of eventually alterations caused 
by P-cadherin downregulation. In accordance with this data, evaluation of cell death by 
PI/annexin V showed that UV-irradiation caused a robust cell death alone and in 
combination with P-cadherin silencing, with no differences between siRNA Scrambled and 
siRNA P-cadherin in both cell lines. Further, the MFE data strength this assumption, since 
no mammospheres were formed in both cell lines irradiated with UV light.  Based on these 
results, we assume that it would be important to test different doses and time points for 
UV- irradiation. Actually, the evaluation of the results obtained by the comet assay 
revealed that UV light caused DNA damage in both cell lines, although BT-20 cells 
showed significantly more sensibility than MCF10A. These differences might be a 
consequence of distinct genomic profiles exhibited between the two cell lines. 
Interestingly, the DNA damage was incremented by the knockdown of P-cadherin in both 
cell lines, suggesting again a putative role of P-cadherin expression in promoting 
resistance to cell DNA damage. Additionally, the evaluation of DSBs by уH2AX foci 
showed the capacity of UV irradiation to promote this type of DNA lesions (Hanasoge and 
Ljungman, 2007). As described, the majority of cell DNA insults induced by UV light are 
the pyrimidine adducts, which are potentially converted in DSBs during S phase of cell 
cycle (Limoli et al., 2002). The differences observed by the DNA DSBs extension between 
the two cell lines could reflect not only the direct effect of UV light, but also the cell cycle 
state. However, it has been also reported that the phosphorylation of уУH2AX could occur 
independently of the cell cycle phase (Hanasoge and Ljungman, 2007; O'Driscoll et al., 
2003). As expected, the expression of pChk1 and pChk2 was increased by the exposure 
to UV light of both cell lines. Curiously, pChk1 levels were higher than pChk2 in BT-20 cell 
line, which is in agreement with the described preferential Chk1 phosphorylation by UV 
light (Heffernan et al., 2002). Although not significant, the silencing of P-cadherin 
expression induced a tendency to increase the expression of pChk1 in both cell lines, 
suggesting an increase of the DNA damage. 
 
Taxol is a taxane widely used in breast cancer treatment in association with 
conventional chemotherapeutic drugs, promoting mitotic catastrophe. Although the 
precisely molecular mechanisms of action remain poorly understood, it is known to 
promote the stabilization of microtubules and abrogation of the cell cycle in metaphase.  
Additionally, although it has been reported that this DNA stress-inducing agent has a less 
clear impact in the DDR/R pathway, there is literature suggesting an indirect induction of 
DNA damage (Branham et al., 2004; Tishler et al., 1995). 
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Before the detailed discussion of the results obtained with this treatment, it is 
important to mention that there was an induced influence by the drug vehicle (DMSO), 
concerning cell death and DNA damage. This would mean that the results observed are, 
at least in part, induced by DMSO, rather than by Taxol. One example is reported by Pal 
et al., which pointed that DMSO exposure not only affects the phenotypic characteristics, 
but also induces significant alteration in gene expression, protein content and functionality 
in differentiated hepatic cells (Pal et al., 2012). As expected, treatment with Taxol, 
abrogated the cell cycle in G2/M phase in both cell lines; accordingly with previous 
observations, P-cadherin downregulation did not induce alterations in the cell cycle profile. 
However, we showed that the P-cadherin inhibition, in association with Taxol, increased 
the cell death in both cells lines, meaning that P-cadherin promotes cell death/apoptosis 
resistance. Our data was corroborated by the significantly decrease of the MFE in BT-20 
cell line and are in agreement with the fact that taxol treatment and P-cadherin inhibition 
have a synergistic effect in decreasing the MFE of cancer cells. Once more, the results 
suggest that P-cadherin has a role in promoting cell death resistance more promptly in 
breast cancer cells compared to MCF10A normal-like breast cells. Notably, the comet 
assay showed a significantly synergetic effect with P-cadherin silencing in terms of DNA 
damage solely in MCF10A cell line. However, we could not see any effect in DNA damage 
measured by уH2AX. Although it has been previously reported that Taxol do not induce 
activation of Chk1 protein (Xiao et al., 2005; Zachos et al., 2007), it was reported that is 
able to activate Chk2 (Chabalier-Taste et al., 2008). Our data showed that Taxol does not 
change the expression levels and phosphorylation of checkpoint proteins to a large 
extent, even when P-cadherin was inhibited.  
 
Taking in account all the results obtained, even assuming that most need to be 
repeated and validated, our data show that P-cadherin expression seems to mediate 
resistance to DNA damage. This is in agreement with previous results reported by our 
group, which demonstrated that P-cadherin mediate cell-death resistance to X-ray 
radiation (Vieira et al., 2012). Moreover, this data corroborates the demonstration that P-
cadherin is a cancer stem cell marker, since cancer stem cells are resistant to standard 
cancer therapies, being related to poor patient prognosis. Thus, finding strategies to target 
this pathway could be a greater approach to increase sensibility of cancer cells to 
conventional therapies, inducing, for instance, synthetic lethality, as reported in HR 
deficient tumours targeted by DNA DSBs-inducing agents. However, P-cadherin inhibition 
can also have an impact in normal cells, rendering them to be more sensitive to DNA 
damage and so toxic effects have to be also considered.  
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Although we do not know how P-cadherin expression impacts in the DNA damage 
repair machinery, we consider the possibility that there is an indirect effect, for example, 
as the result of a crosstalk between P-cadherin-induced signalling and the DDR/R 
pathway. It has already been shown that changes in cell-cell contacts and cellular 
confluence have an impact in the DNA damage response pathway, as well as in the DNA 
damage itself (Kang et al., 2012). Therefore, in light of this study, it would be interesting to 
clarify the activation of the players in the DDR/R pathway considering the effect of cellular 
confluence. Understanding these mechanisms will be important for predicting treatment 
response and for the development of novel treatment strategies that prevent therapy-
resistant tumour cells. Thus, our supposition is that P-cadherin silencing can probably 
increase the sensitization of tumour cells to DNA damaging agents, becoming a potential 
therapeutic approach in concomitant administration with conventional cancer therapies, 
like chemo- or radiation therapy. 
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VI. CONCLUSION 
 
 
With the preliminary data obtained in this work, we could show that P-cadherin has 
a role in mediating resistance to cell death/apoptosis, as well as to DNA damage. 
Moreover, P-cadherin silencing decreased the stem cell potential of normal and cancer 
cells, which could be further decreased after administration of certain DNA stress-inducing 
stimuli. There may be a crosstalk between DDR/R pathway and P-cadherin in order to 
promote DNA damage resistance. P-cadherin has no influence on the cell cycle profile, at 
least in the time point used and in the cell types examined. Thus, more studies will be 
necessary, using different doses and time points.  
Although further experiments still need to be performed, our work points to the 
idea that P-cadherin silencing could increase the sensitization of these cells to DNA 
damaging agents, becoming a potential therapeutic approach in concomitant 
administration with conventional treatment, as chemo- or radiation therapy.  
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VIII. FUTURE PERSPECTIVES 
 
 
Based in our results, we consider that more studies will be needed, to better clarify 
the role of P-cadherin in mediating resistance to cell DNA damage and cell-death. As 
reported, P-cadherin is not only a stem cell marker, but participates actively in mediating 
stem cells proprieties. So, based on these data, it would be interesting to separate cells P-
cadherin positive and negative by FACS and perform the evaluation of the expression of 
key-proteins involved in the DDR/R pathway, combining ChK1 and Chk2 to others, like 
ATM, ATR, BRCA1 and p53. Additionally, other DNA-damage agents should have been 
tested, like neocarzinostatin (NCS), a radiomimetic. Actually, we have some preliminary 
data provided by WB analyses that indicate alterations concerning ATM phosphorylated 
form and P-cadherin expression. Additionally, it would be important, performing DNA 
damage repair kinetics, to compare the capacity between P-cadherin positive and 
negative cells to recover upon DNA damage. Other strategy could be comparing 
mammospheres and monolayer cells and evaluating the parameters aforementioned. 
Additionally, other doses and time points would be tested in order to clarify the crosstalk 
between P-cadherin and DDR/R pathways.      
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